Literature DB >> 175693

Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study.

T C Lo, A L Wiley, F J Ansfield, J H Brandenburg, H L Davis, F F Gollin, R O Johnson, G Ramirez, H Vermund.   

Abstract

In 1961, a randomized study was begun at the University of Wisconsin Medical Center in which the treatment of advanced squamous cell carcinoma of the head and neck with radiation therapy was compared with combined treatment with radiation therapy and 5-Fluorouracil. One hundred and thirty-six patients with primary lesions in the oral cavity, the base of the tongue, and the oropharynx were analyzed. Both local control and survival were better in the combined treatment group than in the group with radiation therapy alone. However, in only the oral cavity patient population was the difference statistically significant. Both acute and late complications were also increased in this group of patients who received combined treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175693     DOI: 10.2214/ajr.126.2.229

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  25 in total

Review 1.  Cerebral astrocytomata--trends in radiotherapy and chemotherapy: a review.

Authors:  A Jones
Journal:  J R Soc Med       Date:  1978-09       Impact factor: 5.344

Review 2.  Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region.

Authors:  Amanda Psyrri; George Fountzilas
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Update in cancer chemotherapy: head and neck cancer, Part 2.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

4.  [Simultaneous radiochemotherapy with carboplatin in patients with inoperable advanced stage III and IV head and neck tumors].

Authors:  R Mücke; M Blynow; P G Ziegler; T Libera; G Kundt; S Dommerich; B Kramp; R Fietkau
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

Review 5.  Head and neck cancer: guidelines for chemotherapy.

Authors:  G Catimel
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 6.  Clinical trials with fluorinated pyrimidines in patients with head and neck cancer.

Authors:  M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 7.  5-Fluorouracil radiation sensitization--a brief review.

Authors:  J E Byfield
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

8.  Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity.

Authors:  Mamoru Tsukuda; Junichi Ishitoya; Yasukazu Mikami; Hideki Matsuda; Choichi Horiuchi; Takahide Taguchi; Kenichi Satake; Toshiro Kawano; Masahiro Takahashi; Goshi Nishimura; Mariko Kawakami; Yasunori Sakuma; Makiko Watanabe; Osamu Shiono; Masanori Komatsu; Yukiko Yamashita
Journal:  Cancer Chemother Pharmacol       Date:  2009-02-15       Impact factor: 3.333

Review 9.  Current role of chemotherapy in head and neck cancer.

Authors:  J S Tobias
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 10.  Locally advanced head and neck cancer.

Authors:  M S Kies; C L Bennett; E E Vokes
Journal:  Curr Treat Options Oncol       Date:  2001-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.